TEL AVIV (Reuters) - Israel-based Teva Pharmaceutical Industries said on Tuesday it had anticipated and planned for a second generic competitor to its multiple sclerosis treatment Copaxone to enter the market in 2018. [Source]
SHANGHAI (Reuters) - Eleven Chinese warships sailed into the East Indian Ocean this month, a Chinese news portal said, amid a constitutional crisis in the tiny tropical island chain of the Maldives now under a state of emergency.
(Reuters Health) - The number of babies dying of suffocation before their first birthday has been rising in recent years, driven at least in part by an increase in the number of parents sharing beds with their infants, a U.S. study suggests.
By Bruno Federowski SAO PAULO, Feb 19 (Reuters) - Brazilian stocks rose on Monday on thin trading volumes following a heavy batch of corporate updates. The benchmark Bovespa stock index rose 0.3 percent, supported by shares of state-controlled oil company Petróleo Brasileiro SA on the heels of rising crude prices. Shares in electronics and appliance retailer Via Varejo SA rose 1.1 percent following solid fourth-quarter earnings figures. Fibria Celulose SA and Suzano Papel e
LONDON, Feb 19 (Reuters) - World stocks were set to post their first loss in five days on Monday, breaking a winning streak that saw them recover almost half their losses from a violent sell-off two weeks ago.
(Reuters Health) - In the first year after being told by a doctor that they have acne, patients’ risk for a diagnosis of major depressive disorder spikes by more than 60 percent compared to the general population, a new study shows.
WASHINGTON (Reuters) - Ten months before the United States votes in its first major election since the 2016 presidential contest, U.S. state election officials huddled in Washington this weekend to swap strategies on dealing with an uninvited guest: Russia.
BLANTYRE (Reuters) - Cholera cases in Malawi have tripled and four more people have died, the Ministry of Health said on Monday, a month after the spread of the disease from Zambia was thought to have been contained.
BEIRUT (Reuters) - Militias allied to the Syrian government will enter the Afrin region within hours, state media reported on Monday, after a reported deal to help Kurdish forces repel a Turkish assault.
Marches are being planned around the US to pressure Congress to pass gun reform and make schools safer
As survivors of Wednesday's school shooting demand that it be the last such massacre, marches are being planned around the country to amplify the students' message that action must be taken to end gun violence.
BEIJING (Reuters) - China will ban fishing in the Yellow River, or Huanghe, between April 1 and June 30 every year starting from 2018, state-owned media Xinhua reported on Monday, citing a statement from the Ministry of Agriculture.
TOKYO, Feb 19 (Reuters) - Asian shares ticked up on Monday, joining a global recovery for equity markets as sentiment improved gradually from a recent shakeout that stemmed from fears of creeping inflation and higher borrowing costs.
NEW YORK (Reuters) - Bond investors, who have been on edge over signs of growing inflation and a possibly more aggressive Federal Reserve, will have their work cut out for them as the U.S. government seeks to sell $258 billion worth of debt this coming week.
BUDAPEST (Reuters) - Hungarian leader Viktor Orban called on Sunday for a global alliance against migration as his right-wing populist Fidesz party began campaigning for an April 8 election in which it is expected to win a third consecutive landslide victory.
(Reuters) - A federal judge in Delaware has overturned a jury's verdict requiring Gilead Sciences Inc to pay a record $2.54 billion because its hepatitis C drugs Sovaldi and Harvoni infringed a patent held by rival Merck & Co Inc.
LONDON (Reuters) - AstraZeneca's immunotherapy drug Imfinzi has won crucial approval from U.S. regulators for use in lung cancer, opening up a multibillion-dollar market for a medicine that has so far lagged behind competitors.
(Reuters Health) - A shortage of clinicians specializing in pediatric behavioral and developmental disorders is translating into long wait times for new patient appointments amid surging demand, a new study suggests.
(Reuters) - The U.S. Food and Drug Administration on Friday granted approval for expanded use of AstraZeneca Plc's, immunotherapy drug, Imfinzi, to treat non-small cell lung cancer whose tumors can't be surgically removed.
BOSTON, Feb 16 (Reuters) - A New Jersey trader filed a lawsuit against Fidelity Investments, accusing it of "gross negligence" because he could not make trades on the company's website earlier this month during a volatile time on the stock market.
(Reuters Health) - Even though elderly people have the highest rates of hospitalization and death from influenza, a U.S. study suggests that older patients may be less likely to get tested for flu in the hospital.
(Reuters Health) - What if someone who lived with the young man who unleashed one of the deadliest school shootings in U.S. history this week had been concerned that he might harm himself or others and removed his AR-15 rifle from his home?
NEW YORK, Feb 16 (Reuters) - Global stocks rose on Friday and were set for their best week in six years as strong corporate earnings offset concerns about rising inflation and interest rates, while the U.S. dollar edged higher from a three-year low against major currencies.
(Reuters) - Switzerland's Novartis AG is preparing to auction its U.S. generic pill business, looking to shed a unit that has struggled amid fierce price competition, people familiar with the matter said on Friday.
(Reuters) - The U.S. Food and Drug Administration on Friday declined to approve Apricus Biosciences Inc's Vitaros, a cream to treat erectile dysfunction, for the second time in a decade, sending the company's shares down more than 70 percent before the opening bell.
MELBOURNE, Feb 16 (Reuters) - Global zinc miners and smelters failed to reach any benchmark deal on 2018 processing terms at an annual industry gathering this week, and any agreement is likely to be delayed by a month or more as participants haggle over prospects for growing supply in the second half, two industry sources told Reuters.
PYEONGCHANG, South Korea (Reuters) - Two Swiss freestyle skiers are the first athletes confirmed to have been hit by a highly contagious virus that causes vomiting and diarrhea at the Pyeongchang Winter Games, the Swiss Olympic team confirmed on Friday.
MEXICO CITY, Feb 15 (Reuters) - Mercado Libre, Latin America's home-grown e-commerce firm, said on Thursday that it would open two large distribution centers in Mexico as part of an effort to improve its logistics in the country.
(Reuters) - Adults who get a flu shot are 36 percent less likely to get the disease, while for children the figure was an unexpectedly high 59 percent, U.S. health officials said on Thursday, predicting that the current "intense" season could continue for weeks.
(Reuters) - U.S. regulators have proposed lowering the bar for clinical trial success for experimental Alzheimer's drugs to better align with the current emphasis on the need to treat people when they are in the earliest stages of the brain-wasting disease.
(Reuters Health) - Patients with severe blockages in leg arteries can sometimes be treated with surgery to reroute blood flow; otherwise they require amputation - which black patients are more likely than whites to get, according to a study of New York State data.
(Reuters Health) - Women who get magnetic resonance imaging (MRI) screening tests for breast cancer are more likely to get invasive surgical biopsies to look for tumors than women who just get screening mammograms, a U.S. study suggests.
(Reuters Health) - Spouses with uncontrolled drinking problems have a “large and rapid” influence on the likelihood their partner will also be diagnosed with an alcohol use disorder, according to a long-term study of married couples in Sweden.
WASHINGTON, Feb 15 (Reuters) - In a boost for electric storage technology, the Federal Energy Regulatory Commission (FERC) on Thursday approved a new rule to remove barriers to batteries and other storage resources in U.S. power markets.
GENEVA (Reuters) - Women in labor should be given more time to give birth and have fewer medical interventions, while participating more in decision-making, the World Health Organization (WHO) said on Thursday.
SEATTLE (Reuters) - XPO Logistics Inc said on Thursday it expects to make or manage 750,000 deliveries of bulky goods like flat-screen televisions and furniture to homes in Europe in 2018, as the U.S.-based company dips its toe into a crowded and fast-growing market.
LONDON (Reuters) - Britain's Indivior is launching a new weapon to fight the U.S. opioid crisis this month, but high hopes for its once-monthly injection were offset on Thursday by the need to set aside more cash for legal disputes.
(Reuters) - United Arab Emirates-based Aster DM Healthcare Ltd's initial public offering (IPO) of shares on the Indian exchanges to raise 9.80 billion rupees ($153.34 million) was subscribed 1.3 times on the last day of the sale on Thursday.
PARIS (Reuters) - French pharma company Ipsen expects to bring more drugs to combat cancer, rare diseases and mobility impairment into its pipeline this year and has around one billion euros ($1.25 billion) for asset purchases, its chief executive said.
LONDON, Feb 15 (Reuters) - Foreign exchange trading volumes have risen sharply since the start of this year, new data showed on Thursday, as investors ramped up bets on a weaker dollar and uncertainty about the end of the era of cheap money stoked volatility.
SINGAPORE, Feb 15 (Reuters) - Electric airplane start-up Eviation Aircraft Ltd is aiming for its 9-seat commuter aircraft to be flying passengers by 2021 after signing up South Korea's Kokam as its battery supplier, the Israeli company's chief executive said on Thursday.
JAKARTA, Feb 15 (Reuters) - The Indonesian unit of Freeport-McMoRan Inc and fellow copper miner Amman Mineral Nusa Tenggara (AMNT) are waiting for last-minute mining ministry approvals to their applications to extend copper concentrate exports, company officials said.
LONDON (Reuters) - Britain's Indivior, which makes drugs to treat opioid addiction and plans to launch a key new product this month, said on Thursday it had increased provisions for investigative and antitrust litigation matters to $438 million.
LONDON (Reuters) - Britain's Oxford BioMedica has won a second $100 million contract to supply gene therapy material, this time from Bioverativ, which agreed last month to be acquired by Sanofi for $11.6 billion.
SINGAPORE (Reuters) - Just over a year into production cuts lead by OPEC and Russia, oil markets in Asia have tightened noticeably as significant amounts of excess crude have been taken off tankers used for storage and delivered to customers across the region.
MEXICO CITY (Reuters) - A meeting between U.S. President Donald Trump and Mexico's Enrique Pena Nieto is being planned for sometime during the next few weeks, Mexico's foreign ministry said in a statement on Wednesday.
(Reuters) - Cisco Systems Inc reported its first rise in quarterly revenue in more than two years and forecast upbeat current-quarter profit, as the network gear maker's years-long efforts to transform into a software-focused company begins to pay off.
(Reuters) - Warren Buffett's Berkshire Hathaway Inc on Wednesday disclosed a new stake in generic drugmaker Teva Pharmaceutical Industries Ltd and said it bought more shares of Apple Inc , which surpassed Wells Fargo & Co as its largest common stock investment.
(Reuters Health) - Women whose postpartum depression lasts for several months are at heightened risk of having depression that lingers for years and it may affect their children, showing up as behavior problems and increased depression risk in the teenage years, a UK study suggests.
(Reuters) - Warren Buffett's Berkshire Hathaway Inc on Wednesday said it has taken a new stake in Teva Pharmaceutical Industries Ltd , significantly boosted its holdings of Apple Inc and has nearly shed a less successful investment in IBM Corp .
WASHINGTON (Reuters) - United States health spending is projected to rise 5.3 percent in 2018, reflecting rising prices of medical goods and services and higher Medicaid costs, a U.S. government health agency said on Wednesday, an upward trend it forecasts for the next decade.
(Reuters Health) - A federal assistance program designed to move low-income families toward financial independence comes up short – but results might improve if families also receive support that helps them deal with traumatic experiences, a new study suggests.
(Reuters) - The U.S. Food and Drug Administration on Wednesday approved Johnson & Johnson's Erleada treatment for use in prostate cancer patients whose cancer has not spread but continues to grow despite hormone therapy.
WASHINGTON (Reuters) - The Federal Trade Commission should be open to investigating big tech firms like Google or Facebook if they use their power inappropriately and should create a drug pricing task force to identify unusual price increases, Joe Simons said at a hearing to consider his nomination to head the agency.
(Reuters Health) - Even as a growing number of cancer patients are setting up accounts for online access to medical charts, fewer people are actually logging on to look at their test results, a U.S. study suggests.
MEXICO CITY, Feb 14 (Reuters) - America Movil, Mexico's largest telecommunications firm, will increase capital expenditures to around $8 billion this year, Chief Executive Officer Daniel Hajj said during a call with analysts on Wednesday.
FORT MEADE, Md (Reuters) - Several people were injured on Wednesday when an unauthorized motorist tried to drive onto the campus of the U.S. National Security Agency near Washington, prompting guards to open fire on the vehicle, officials said.
TORONTO, Feb 14 (Reuters) - Teck Resources Ltd, the world's second-biggest exporter of steelmaking coal, said on Wednesday that growing global steel production is expected to boost demand for its coal in 2018, though coal trade competition will also likely rise.
NEW YORK, Feb 14 (Reuters) - U.S. debt prices fell on Wednesday after a spike in U.S. consumer prices in January raised expectations the Federal Reserve may quicken the pace of interest rate hikes, while global stocks rose as investors took a longer view of inflation.
PARIS (Reuters) - Ghana has reported an outbreak of the highly pathogenic H9N2 bird flu virus on a farm in the southwest of the country, the Paris-based World Organisation for Animal Health (OIE) said on Wednesday, citing a report from Ghana's agriculture ministry.
STOCKHOLM (Reuters) - American heavy metal band Metallica was awarded Sweden's Polar Music Prize on Wednesday, drawing a delighted response from the group which has sold more than 100 million records worldwide.
PARIS (Reuters) - French retailers, defending their role in a contaminated baby milk scandal on Wednesday, said they had received products after the recall deadline and that communication by dairy producer Lactalis was confusing.
LONDON (Reuters) - As OPEC watches a near 15 percent drop in the oil price in three weeks, important indicators in the physical crude market are flashing signals that the decline might be far from over.
(Reuters) - Bristol-Myers Squibb Co will pay Nektar Therapeutics $1.85 billion in cash and share purchase for a global development and commercialization deal on a promising Nektar cancer drug, the companies announced on Wednesday.
LONDON, Feb 14 (Reuters) - Emerging stocks extended their rally for a third day and a weaker dollar lifted currencies ahead of a key U.S. inflation report on Wednesday while South Africa investors were poised for the next twist in the saga over President Jacob Zuma's future.
JERUSALEM, Feb 14 (Reuters) - Israel Chemicals (ICL) reported on Wednesday higher revenue and profit in the fourth quarter, beating expectations as potash prices rose and expenses fell at the world's sixth-largest producer of the fertiliser ingredient.
LONDON, Feb 14 (Reuters) - The dollar slid to a 15-month low against the yen on Wednesday, while world stock markets found firmer ground ahead of U.S. inflation numbers that could soothe, or inflame, fears of faster interest-rate hikes globally.
WASHINGTON (Reuters) - Leaders of U.S. intelligence agencies warned on Tuesday that Russia will try to interfere in the 2018 U.S. midterm elections by using social media to spread propaganda and misleading reports, much as it did in the 2016 campaign.
(Reuters) - U.S. financial markets have been roiled recently by something neither the economy nor investors have had to contend with for the better part of a decade: concerns they may soon have to reckon with rising inflation.
NEW YORK (Reuters) - Merck & Co Inc on Tuesday said it will end another late-stage trial of an Alzheimer's drug because it was unlikely to work, adding to the pile-up of failures to find an effective treatment for the mind-wasting disease.
(Reuters) - Tetraphase Pharmaceuticals Inc said on Tuesday its lead experimental antibiotic to treat serious infections did not meet the main goals in a late-stage study, sending its shares plunging more than 60 percent in after-market trading.
NEW YORK (Reuters) - Blue Apron Holdings Inc said on Tuesday it could break even on a key measure of profitability earlier than Wall Street analysts had expected, fueling a brief surge in the meal-kit maker's shares.
DAYTON, Ohio (Reuters) - When the Federal Reserve's policy meeting ended last month, U.S. stock indexes were near record highs, market volatility was almost non-existent and policymakers chatted about the calm waters welcoming incoming central bank chief Jerome Powell.
WASHINGTON (Reuters) - Top U.S. national security officials said on Tuesday they had "no doubt" Russia will try to interfere in the 2018 U.S. mid-term elections, adding Moscow believes it succeeded in its effort to undermine U.S. democracy by meddling in the 2016 presidential campaign.
(Reuters Health) - Physicians at some of the nation’s most elite medical schools don’t receive three months of paid parental leave that doctors recommend for the health of mothers and babies, a U.S. study has found.
PARIS (Reuters) - French dairy group Lactalis, which is facing a growing scandal over salmonella-tainted baby milk, did not report the bacteria had been found on products in the same factory in 2011 despite an obligation to do so, a government official said on Tuesday.
(Reuters Health) - Women are more likely to develop breast cancer when a mother or sister had this disease, and the risk associated with family history doesn’t appear to diminish with age, a U.S. study suggests.
NEW YORK, Feb 13 (Reuters) - U.S. bond yields and world equity markets dipped on Tuesday, ahead of a widely anticipated U.S. inflation report later this week that may provide some indication of the pace of future interest rate hikes by the Federal Reserve.
LONDON (Reuters) - European oncologists will soon get their hands on cut-price copies of breast cancer drug Herceptin, turning the screws on maker Roche and giving another boost to a new breed of companies focused on so-called biosimilars.
(Reuters) - Walgreens' potential deal for drug distributor AmerisourceBergen will boost its cash flow and push it deeper into a lucrative specialty pharmacy market, but may fail to keep it competitive in an evolving U.S. healthcare sector, analysts said.
(Reuters) - A federal judge has ruled the U.S. Justice Department can move forward with a lawsuit claiming UnitedHealth Group Inc wrongly retained more than $1 billion from the government healthcare program Medicare.
(Reuters) - German biotech firm CureVac has secured more financial backing for vaccine development projects from its investor the Bill & Melinda Gates Foundation, working on jabs to prevent malaria and influenza.
TEL AVIV (Reuters) - Israel-based Teva Pharmaceutical Industries said on Tuesday it had anticipated and planned for a second generic competitor to its multiple sclerosis treatment Copaxone to enter the market in 2018.
NEW YORK (Reuters) - Blue Apron Holdings Inc shares jumped 9 percent in premarket trading on Tuesday after the meal-kit maker reported a smaller-than-expected revenue drop and quarterly loss as a costly distribution hub switch forced it to slash marketing.
TEL AVIV (Reuters) - The British embassy in Israel said on Tuesday it has launched a program designed to help incorporate Israeli digital health technology into the UK and its National Health Service (NHS).
LONDON, Feb 13 (Reuters) - The fight between Goldilocks bets - on the not too hot, not too cold global economy - and market bears who have delivered some hefty blows in recent weeks, continued on Tuesday with little sign yet of a clear winner.
ZURICH (Reuters) - Novartis's Sandoz division has won U.S. approval for a larger dosage of its Glatopa drug for multiple sclerosis (MS) patients, ending a costly delay that allowed rival generics makers to beat it to market.
NEW YORK (Reuters) - An Oregon woman has become the first person worldwide known to have had an eye infestation by a tiny worm species previously seen only in cattle that is spread by flies that feed on eyeball lubrication, U.S. government researchers said on Monday.
(Reuters Health) - People with anxiety and depression might feel a little better after they get mild electric shock therapy, but it’s unclear how much it will help or whether this treatment might ease other conditions, researchers say.
(Reuters Health) - While a nationwide push to get babies to sleep on their backs initially produced steep declines in unexplained and sleep-related infant deaths, U.S. progress against these fatalities has been minimal in recent years.
NEW YORK, Feb 12 (Reuters) - World shares rallied on Monday in a broad advance that brushed off fresh rises in global bond yields that have been driven by inflation fears as investors shifted asset allocations after the worst week in global markets in the past two years.
OSLO (Reuters) - Norwegian authorities will buy the rare-disease treatment Spinraza for patients from U.S. drugmaker Biogen Inc at a cost of 7 million Norwegian crowns ($880,381.33) per year per patient, public broadcaster NRK reported on Monday.
LONDON, Feb 12 (Reuters) - Emerging stocks bounced off 1-1/2 month lows on Monday, snapping a seven-day losing streak as developed equity markets steadied, while South African markets gained ahead of a meeting set to decide President Jacob Zuma's fate.
LONDON, Feb 9 (Reuters) - Market seismographs are still twitching at levels almost twice the historical average and Wall Street's gauge of implied volatility needs to return below 20 percent for stocks to stabilise.
SYDNEY, Feb 12 (Reuters) - Asian share markets found a semblance of calm on Monday as S&P futures extended their bounce, though global investors were still fretting about the risks from looming U.S. inflation data after last week's sharp sell-off.
PYEONGCHANG, South Korea (Reuters) - Pyeongchang Winter Olympics organizers (POCOG) said on Monday a total of 177 norovirus cases had been confirmed so far at the Games but that the athletic delegations remained unaffected.
SYDNEY, Feb 12 (Reuters) - Asian share markets were struggling to find their footing on Monday as investors fretted about the risks from looming U.S. inflation data, although early gains on S&P futures offered a sliver of support.
DUBAI, Feb 11 (Reuters) - Sharp swings in global financial markets in the past few days are not worrying since economic growth is strong but reforms are still needed to avert future crises, the managing director of the International Monetary Fund said on Sunday.
DUBAI, Feb 11 (Reuters) - Sharp fluctuations in global equity markets and other markets in the past few days are not worrying, as global economic growth is strong and available financing is ample, International Monetary Fund managing director Christine Lagarde said on Sunday.
(Reuters) - OxyContin maker Purdue Pharma LP said on Saturday that it has cut its sales force in half and will stop promoting opioids to physicians, following widespread criticism of the ways that drugmakers market addictive painkillers.
PYEONGCHANG, South Korea (Reuters) - Pyeongchang Winter Olympics organizers said on Saturday that 11 new cases of a virus that causes vomiting and diarrhea had been confirmed at the Games, bringing the total to 139.
(Reuters Health) - Children who play with second-hand plastic toys may be exposed to unsafe levels of chemicals like lead and cadmium that have been linked to developmental problems and organ damage, a UK study suggests.
WASHINGTON (Reuters) - A U.S. budget deal adopted by Congress on Friday includes what advocates call a landmark compromise to provide an estimated $1.5 billion over 10 years to try to keep struggling families together, including those with babies born dependent on opioids.
(Reuters) - One of the worst flu outbreaks in the United States in nearly a decade worsened last week and will likely linger for several weeks, causing more deaths, the Centers for Disease Control and Prevention said on Friday.
(Reuters Health) - People with a history of migraines may be more likely to develop cardiovascular problems like heart attacks, stroke, and an irregular heart beat than individuals who don’t experience these headaches, a Danish study suggests.
WASHINGTON (Reuters) - A U.S. budget deal adopted by Congress on Friday includes what advocates call a landmark compromise to provide an estimated $1.5 billion over 10 years to try to keep struggling families together, including those with babies born dependent on opioids.
PARIS (Reuters) - Four tobacco companies operating in France manipulated tests to conceal the real level of nicotine and tar contained in cigarettes, endangering the lives of smokers, a French anti-smoking organization alleged in a legal complaint.
WASHINGTON (Reuters) - The Trump administration is proposing ways to curb the cost of prescription drugs for seniors and other Americans, the Wall Street Journal reported on Friday, acting on repeated pledges by President Donald Trump to tackle rising prices.
(Reuters Health) - Insecticide foggers, also known as “bug bombs,” are still causing illnesses in the U.S., even after manufacturers were ordered to change the products' labels to make them safer, researchers say.
ZURICH (Reuters) - Britain's healthcare watchdog (NICE) recommended Roche's medicine Gazyvaro for previously untreated advanced follicular lymphoma patients after initially rejecting the Swiss drugmaker's medicine last year as too expensive.
(Reuters) - Shares of U.S. online travel services company Expedia fell 19 percent in premarket trading on Friday, after forecasting 2018 selling and marketing costs would outpace revenue growth as it battles rivals for market share.
WASHINGTON (Reuters) - The U.S. federal government on Thursday approved a device made by a private company in Wisconsin that will allow the first domestic production of a medical imaging isotope in 25 years, a move the government said would enhance national security by reducing the need to transport weapons-grade uranium.
WASHINGTON/CHICAGO (Reuters) - U.S. lawmakers are close to resolving a problem with the new federal tax law that gives grain cooperatives an unintended market edge over private companies, but have struggled to get members of the farm sector to agree, a Republican senator said on Thursday.
PYEONGCHANG, South Korea (Reuters) - Olympic officials are discussing measures to combat the spread of a virus that causes vomiting and diarrhea after 42 new cases were confirmed at the Winter Games, a Korean Centers for Disease Control and Prevention (KCDC) official said on Friday.